Panel Endorses HIV Drug Truvada for FDA Approval

Friday, May 11, 2012

We have known about Truvada for a while. Now, an influential advisory panel of the Food and Drug Administration has endorsed the drug shown to prevent HIV infection in healthy people. It recommended approval of the pill for people at risk of contracting the virus. A final decision is expected next month, but if FDA does approve, it won't be without a degree of controversy. We're joined by Dr. Kenneth Mayer, medical research director at Fenway Health in Boston and a professor at Harvard Medical School.

Guests:

Dr. Kenneth Mayer

Produced by:

Javier Guzman and Elizabeth Ross

Leave a Comment

Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.